Drug Abuse Warning Network


Also found in: Dictionary, Thesaurus, Legal, Acronyms, Encyclopedia, Wikipedia.

Drug Abuse Warning Network (DAWN)

a system of collecting information about admissions to emergency treatment facilities for drug abuse.

Drug Abuse Warning Network

,

DAWN

A national system of surveillance that records the number of deaths and emergency department visits caused by illicit drugs. It was renamed “New DAWN” in 2003.
References in periodicals archive ?
1995), for example, assessed the capabilities of the Drug Abuse Warning Network (DAWN) and concluded that despite a number of methodological limitations, there were measurements for which DAWN offered an appropriate yardstick, most noticeably identifying jurisdictional patterns of drug abuse (Caulkins et al.
Together with the Substance Abuse and Mental Health Services Administration (SAMHSA), the CDC reviewed the latest available 5 years of data on emergency department (ED) visits for nonmedical use of prescription drugs from SAMHSA's Drug Abuse Warning Network (DAWN).
The researchers matched the autopsy records with information in the Drug Abuse Warning Network (DAWN) database, which was set up by the Drug Enforcement Agency to collect mortality data from medical examiners and emergency room personnel.
DAWN Medical Examiner Mentions (1999) Drug Mentions diazepam (Valium) 811 diphenhydramine (Benadryl) 641 Elavil (antidepressant) 477 nortriptyline (antidepressant) 424 acetaminophen (Tylenol) 427 lidocaine (heart drug & local 384 anesthetic) Prozac 305 quinine 250 meprobamate (tranquilizer) 170 aspirin 104 Source: Drug Abuse Warning Network
Since 1972 the Drug Abuse Warning Network (DAWN) has collected data on the incidence of emergency room episodes related to drug abuse.
Data Source: A review by the Centers for Disease and Prevention of 5-year data on ED visits involving the nonmedical use of prescription drugs from the Substance Abuse and Mental Health Services Administration's Drug Abuse Warning Network.
To better understand recent national trends in drug-related morbidity, CDC and the Substance Abuse and Mental Health Services Administration (SAMHSA) reviewed the most recent 5 years of available data (2004-2008) on ED visits involving the nonmedical use of prescription drugs from SAMHSA's Drug Abuse Warning Network (DAWN).
Given the millions of doses consumed each year, such cases are remarkably rare: The Drug Abuse Warning Network counted nine MDMA-related deaths in 1998.
The National Hospital Ambulatory Medical Care Survey (NHAMCS) (7) has been used to describe outpatient adverse reactions, and the Drug Abuse Warning Network (DAWN) recently modified data-collection procedures to include adverse reactions (8); similar assessment of these systems might be appropriate.
During 1999, 129 inhalant deaths were reported to SAMHSA's Drug Abuse Warning Network (DAWN) by 139 medical examiner facilities in 40 U.

Full browser ?